HealthQuill Abbott
The US drug regulator, FDA, did not have an organizational structure or assigned responsibilities to handle whistleblower complaints “efficiently and effectively” and took more than 15 months to address a February 2021 Abbott facility whistleblower complaint, according to a federal audit.
Drugs Health Pharma

US audit finds gaps in FDA’s procedures during infant formula crisis

The US drug regulator, FDA, did not have an organizational structure or assigned responsibilities to handle whistleblower complaints “efficiently and effectively” and took.

Read More
A blood protein, called fibrin, which supports clotting, is responsible for switching on detrimental genes in Alzheimer’s disease and multiple sclerosis, researchers say.
Health Medical Pharma

FDA clears Abbott’s rapid blood test for concussion assessment

HQ  Team April 18, 2024: The Food and Drug Administration (FDA) has cleared Abbot’s i-STAT TBI cartridge for rapid assessment of mild traumatic.

Read More
X